- Home
- IAG vs JANX Comparison
IAG vs JANX Comparison
Compare IAG & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IAG
- JANX
- Stock Information
- Founded
- IAG 1990
- JANX 2017
- Country
- IAG Canada
- JANX United States
- Employees
- IAG N/A
- JANX N/A
- Industry
- IAG Precious Metals
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- IAG Basic Materials
- JANX Health Care
- Exchange
- IAG Nasdaq
- JANX Nasdaq
- Market Cap
- IAG 3.2B
- JANX 2.9B
- IPO Year
- IAG 1996
- JANX 2021
- Fundamental
- Price
- IAG $5.70
- JANX $46.50
- Analyst Decision
- IAG Buy
- JANX Strong Buy
- Analyst Count
- IAG 6
- JANX 10
- Target Price
- IAG $7.40
- JANX $65.10
- AVG Volume (30 Days)
- IAG 7.4M
- JANX 637.5K
- Earning Date
- IAG 11-07-2024
- JANX 11-06-2024
- Dividend Yield
- IAG N/A
- JANX N/A
- EPS Growth
- IAG 420.20
- JANX N/A
- EPS
- IAG 1.38
- JANX N/A
- Revenue
- IAG $1,460,700,000.00
- JANX $13,049,000.00
- Revenue This Year
- IAG $68.68
- JANX $66.30
- Revenue Next Year
- IAG $38.44
- JANX N/A
- P/E Ratio
- IAG $4.10
- JANX N/A
- Revenue Growth
- IAG 62.90
- JANX 54.12
- 52 Week Low
- IAG $2.11
- JANX $7.79
- 52 Week High
- IAG $6.37
- JANX $65.60
- Technical
- Relative Strength Index (RSI)
- IAG 58.43
- JANX 33.84
- Support Level
- IAG $4.89
- JANX $47.04
- Resistance Level
- IAG $5.88
- JANX $49.74
- Average True Range (ATR)
- IAG 0.24
- JANX 2.88
- MACD
- IAG 0.03
- JANX -1.00
- Stochastic Oscillator
- IAG 81.82
- JANX 4.54
About IAG Iamgold Corporation
Iamgold Corp is a mid-tier gold mining company. The company operating gold mines are divided into geographic segments such as Burkina Faso - Essakane mine, Canada - Doyon division, including Westwood mine. The company's s non-gold mine segments are the Cote Gold project, Exploration and evaluation and development, and Corporate - which includes royalty interests. The company generates the majority of its revenue from the Burkina Faso segment.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.